In reply

International Journal of Tuberculosis and Lung Disease

Volumn 19, Issue 10, 2015, Pages 1264-

  Johnston, James C ^a   Khan, Faiz Ahmad ^b   Dowdy, David W ^c  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

DISEASE ELIMINATION; DRUG SUSCEPTIBLE TUBERCULOSIS; HIGH RISK PATIENT; HUMAN; LETTER; PATIENT ADVOCACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RELAPSE; TREATMENT OUTCOME; TUBERCULOSIS; STANDARDS; WORLD HEALTH ORGANIZATION;

ANTITUBERCULAR AGENTS; HUMANS; PRACTICE GUIDELINES AS TOPIC; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

EID: 84942789821     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.15.0518-2     Document Type: Letter

References (0)